CLINICAL_TRIALS
trial_result
· 2011-03-02
Clinical Trial Update: Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma [Phase 2]
Summary
A Phase 2 trial evaluating the effect of levalbuterol on allergen-induced airway inflammation in subjects with atopic asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hamilton Health Sciences Corporation | Conditions: Asthma | Phase 2 | Status: COMPLETED